Insider Stock Trading History of Booth Mark D


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Booth Mark D since year 2005. The trader's CIK number is 1470885. At the time of this reporting, Booth Mark D is the Chief Commercial Officer of Orexigen Therapeutics, Inc. . (stock ticker symbol OREX). See this page for all insider trading activities at Orexigen Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Booth Mark D since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-02-26 OREX Orexigen Therapeutics, Inc. Sale 50,000 5.68 284,200
2015-02-26 OREX Orexigen Therapeutics, Inc. Option Ex 50,000 1.66 83,000
2013-07-26 OREX Orexigen Therapeutics, Inc. Option Ex 64,767 1.66 107,513
2013-07-26 OREX Orexigen Therapeutics, Inc. Sale 64,767 7.50 485,752
2013-03-11 OREX Orexigen Therapeutics, Inc. Option Ex 27,685 1.66 45,957
2013-03-11 OREX Orexigen Therapeutics, Inc. Sale 27,685 6.67 184,658
2013-01-15 OREX Orexigen Therapeutics, Inc. Option Ex 22,315 1.66 37,042
2013-01-15 OREX Orexigen Therapeutics, Inc. Sale 22,315 6.67 148,907
2012-06-28 OREX Orexigen Therapeutics, Inc. Sale 103,309 5.66 584,728
2012-06-28 OREX Orexigen Therapeutics, Inc. Option Ex 103,309 1.66 171,492

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Booth Mark D (Chief Commercial Officer of Orexigen Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.